The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
Open accessAbstract
Glucocorticoid-induced osteoporosis may be due, in part, to increased apoptosis of osteocytes and osteoblasts, and bisphosphonates (BPs) are effective in the management of this condition. We have tested the hypothesis that BPs suppress apoptosis in these cell types. Etidronate, alendronate, pamidronate, olpadronate, or amino-olpadronate (IG9402, a bisphosphonate that lacks antiresorptive activity) at 10(-9) to 10(-6) M prevented apoptosis of murine osteocytic MLO-Y4 cells, whether it was induced by etoposide, TNF-alpha, or the synthetic glucocorticoid dexamethasone. BPs also inhibited apoptosis of primary murine osteoblastic cells isolated from calvaria. Similar antiapoptotic effects on MLO-Y4 and osteoblastic cells were seen with nanomolar concentrations of the peptide hormone calcitonin. The antiapoptotic effect of BPs and calcitonin was associated with a rapid increase in the phosphorylated fraction of extracellular signal regulated kinases (ERKs) and was blocked by specific inhibitors of ERK activation. Consistent with these in vitro results, alendronate abolished the increased prevalence of apoptosis in vertebral cancellous bone osteocytes and osteoblasts that follows prednisolone administration to mice. These results suggest that the therapeutic efficacy of BPs or calcitonin in diseases such as glucocorticoid-induced osteoporosis may be due, in part, to their ability to prevent osteocyte and osteoblast apoptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Induction of apoptosis in MLO/Y4 cells by etoposide, TNF-␣, or glucocorticoids was prevented by pretreatment of the cells with 5-10 ng/mL sCT.”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [167]
The cited source says what the claim attributes to it.
In the citing paper
“The authors suggest that the therapeutic effect of calcitonin in diseases such as glucocorticoid-induced osteoporosis may be partly due to inhibition of osteocyte apoptosis (167).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [167]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thornberry, N. A., & Lazebnik, Y. A. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,857
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., & Greenberg, M. E. (1995) · Science · doi:10.1126/science.270.5240.1326 · Cited by 5,273
Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,374
Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Dyk, D. E. V., Pitts, W. J., Earl, R. A., Hobbs, F. W., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18623 · Cited by 3,016
The Fire of Life: An Introduction to Animal Energetics
Kleiber, M. (1975) · Medical Entomology and Zoology · Cited by 2,529
A short amino acid sequence able to specify nuclear location
Kalderon, D., Roberts, B., Richardson, W. D., & Smith, A. E. (1984) · Cell · doi:10.1016/0092-8674(84)90457-4 · Cited by 2,511
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753 · cited 12×
“The TUNEL reaction was performed according to the manufacturer’s instructions, using 0.15% CuSO4 for color enhancement.”
BackgroundMethodResultInfluentialSelf-citationLuckman, S. P., Hughes, D. E., Coxon, F. P., Russell, R. G. G., & Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.581 · Cited by 1,176
DNA binding of the glucocorticoid receptor is not essential for survival
Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068
Research works printed but not linked: 8
- Cummings, 1996, J Bone Miner Res, 11(Suppl.), S102
- Marotti, 1990, Ital J Miner Electrol Metab, 4, 93
- Dennison, 1999, Osteoporos Int, 9, S16
- Weinstein, 1998, Bone, 23(Suppl), S461
- Falcini, 1996, Calcif Tissue Int, 58, 166
- Grignani, 1998, Cancer Res, 58, 14
- Giuliani, 1995, J Bone Miner Res, 10(Suppl), S171
- Marotti, 1996, Ital J Anat Embryol, 101, 25
Cited by
Sorted by citations
Items 501–600 of 888
Lau, C., Huang, L., Tsui, S. K., Ng, P. K., Leung, P., & Kumta, S. M. (2010) · Journal of Orthopaedic Research® · doi:10.1002/jor.21249 · Cited by 21
Calcitonin Receptor Gene and Breast Cancer: Quantitative Analysis with Laser Capture Microdissection
Wang, X., Nakamura, M., Mori, I., Takeda, K., Nakamura, Y., Utsunomiya, H., Yoshimura, G., Sakurai, T., & Kakudo, K. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000010703.59483.c0 · Cited by 21
The Hidden Face of Venous Malformations
Redondo, P. (2008) · Archives of Dermatology · doi:10.1001/archderm.144.7.922 · Cited by 21
Osteoblastic protein tyrosine phosphatases inhibition and connexin 43 phosphorylation by alendronate
Lezcano, V., Bellido, T., Plotkin, L. I., Boland, R., & Morelli, S. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.03.016 · Cited by 20
Self-citationFujita, Y., Watanabe, K., Uchikanbori, S., & Maki, K. (2011) · American Journal of Orthodontics and Dentofacial Orthopedics · doi:10.1016/j.ajodo.2009.05.028 · Cited by 20
Cai, G., Laslett, L. L., Aitken, D. A., Cicuttini, F., MARCH, L. M., Hill, C. L., Winzenberg, T. M., & Jones, G. (2019) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x19880054 · Cited by 20
Goodship, A., Blunn, G., Green, J. R., & Coathup, M. (2008) · Journal of Orthopaedic Research · doi:10.1002/jor.20533 · Cited by 21
Risedronate increases osteoblastic differentiation and function through connexin43
Jeong, H. M., Jin, Y.-H., Choi, Y.-H., Chung, J. O., Cho, D. H., Chung, M. Y., Civitelli, R., Chung, D. J., & Lee, K. Y. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.01.068 · Cited by 20
Animal Models in Osteoporosis Research
Kimmel, D. B. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1.50197-9 · Cited by 20
Terpos, E., Palermos, J., Viniou, N., Vaiopoulos, G., Meletis, J., & Yataganas, X. (2001) · Calcified Tissue International · doi:10.1007/bf02390835 · Cited by 20
Kang, A. R., Oh, Y. R., Kim, H. Y., Park, M. J., Joo, B. S., Choi, W. J., Lee, J. Y., Jung, M. H., Ji, Y. I., & Choi, J. S. (2011) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-2141-1 · Cited by 19
Morishita (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000167 · Cited by 19
Ekeuku, S. O., Ramli, E. S. M., Sani, N. A., Ghafar, N. A., Soelaiman, I. N., & Chin, K. (2022) · Molecules · doi:10.3390/molecules27185862 · Cited by 19
Effect of progesterone on apoptosis of murine MC3T3-E1 osteoblastic cells
Wang, Q.-P., Xie, H., Yuan, L., Luo, X., Li, H., Wang, D., Meng, P., & Liao, E.-Y. (2008) · Amino Acids · doi:10.1007/s00726-008-0028-7 · Cited by 19
Lewiecki, E. M., Bilezikian, J. P., Laster, A. J., Miller, P. D., Recker, R. R., Russell, R. G. G., & Whyte, M. P. (2010) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2009.12.003 · Cited by 19
Xie, H., Tang, L.-L., Luo, X., Wu, X., Wu, X., Zhou, H., Yuan, L., & Liao, E.-Y. (2009) · Amino Acids · doi:10.1007/s00726-009-0325-9 · Cited by 19
Bilateral Femoral Head Osteonecrosis After Septic Shock and Multiorgan Failure
Bolland, M. J., Hood, G., Bastin, S., King, A. R., & Grey, A. B. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301250 · Cited by 19
Calcitonin decreases the adherence and survival of HEK-293 cells by a caspase-independent mechanism
Findlay, D., Raggatt, L. J., Bouralexis, S., Hay, S. J., Atkins, G. J., & Evdokiou, A. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750715 · Cited by 19
Bisphosphonates in the Management of Postmenopausal Osteoporosis
Papapoulos, S. E. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50073-8 · Cited by 19
Abe, T., Sato, T., Kokabu, S., Hori, N., Shimamura, Y., Sato, T., & Yoda, T. (2016) · Cytokine · doi:10.1016/j.cyto.2016.03.012 · Cited by 19
The effect of risedronate on orthodontic tooth movement in ovariectomized rats
Wu, D., Meng, B., Cheng, Y., Gan, L., Huang, P., & Cao, Y. (2019) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2019.06.007 · Cited by 18
Malformaciones vasculares (II). Diagnóstico, histopatología y tratamiento
Redondo, P. (2007) · Actas Dermo-Sifiliográficas · doi:10.1016/s0001-7310(07)70055-8 · Cited by 18
RSK2 protects mice against TNF-induced bone loss
Böhm, C., Derer, A., Axmann, R., Hillienhoff, U., Zaiss, M. M., Luther, J., Zech, C., Stock, M., Scholtysek, C., Engelke, K., et al. (2012) · Journal of Cell Science · doi:10.1242/jcs.096008 · Cited by 18
Osteoarthritis and osteoporosis in postmenopausal women: clinical similarities and differences
Avcı, D. K., & Bachmann, G. A. (2004) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000119985.45613.7e · Cited by 18
Successful treatment of avascular bone necrosis of the knee with neridronate: a case report
Corrado, A., Quarta, L., Errico, S., & Cantatore, F. P. (2007) · Rheumatology International · doi:10.1007/s00296-007-0306-9 · Cited by 18
Plotkin, H., Primorac, D., & Rowe, D. W. (2003) · Elsevier eBooks · doi:10.1016/b978-012286551-0/50020-8 · Cited by 18
Davison, K. S., Siminoski, K. G., Adachi, J. D., Hanley, D. A., Goltzman, D., Hodsman, A. B., Josse, R. G., Kaiser, S., Olszynski, W. P., Παπαϊωάννου, Α., et al. (2006) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2006.04.001 · Cited by 17
Lian, J. B., & Stein, G. S. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50003-9 · Cited by 18
Glucocorticoid-Induced Osteoporosis
Lukert, B. P. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-740-6_36 · Cited by 19
Ye, T., Cao, P., Jin, Q., Zhou, Q., Rao, D. S., & Qiu, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186012 · Cited by 17
Khalid, S., Calderón‐Larrañaga, S., Hawley, S. J., Ali, M. S., Judge, A., Arden, N., van Staa, T. P., Cooper, C. C., Javaid, M. K., & Prieto‐Alhambra, D. (2018) · Clinical Epidemiology · doi:10.2147/clep.s164112 · Cited by 17
Palmieri, M., Kim, H., Gómez-Acevedo, H., Que, X., Tsimikas, S., Jilka, R. L., Manolagas, S. C., Witztum, J. L., & Ambrogini, E. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4173 · Cited by 17
Self-citationLethal cervical abscess following bisphosphonate related osteonecrosis of the jaw
Kähling, C., Streckbein, P., Schmermund, D., Henrich, M., Burchert, D., Gattenloehner, S., Howaldt, H., & Wilbrand, J.-F. (2014) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2014.02.009 · Cited by 17
The effect of vitamin D and bisphosphonate on fracture healing: An experimental study
Aydoğan, N. H., Özel, İ., İltar, S., Kara, T., Özmeriç, A., & Alemdaroğlu, K. B. (2016) · Journal of Clinical Orthopaedics and Trauma · doi:10.1016/j.jcot.2016.01.003 · Cited by 17
Biochemical Markers of Bone Turnover in Osteoporosis
Szulc, P., & Bauer, D. C. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00067-4 · Cited by 22
The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts
Enjuanes, A., Ruiz-Gaspà, S., Peris, P., Ozalla, D., Álvarez, L., Combalía, A., de Osaba, M. J. M., Monegal, A., Parés, A. R., & Guañabens, N. (2010) · Endocrine · doi:10.1007/s12020-009-9306-8 · Cited by 17
Kieferknochennekrosen als mögliche unerwünschte Wirkung von Bisphosphonaten
Hoefert, S., & Eufinger, H. (2005) · Oral and Maxillofacial Surgery · doi:10.1007/s10006-005-0624-6 · Cited by 17
Morreale, G., Lee, E. G., Jones, D. B., & Middelberg, A. P. J. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20209 · Cited by 17
Effects of neridronate treatment in elderly women with osteoporosis
Cascella, T., Musella, T., Orio, F., Palomba, S., Bifulco, G., Nappi, C., Lombardi, G., Colao, A., & Tauchmanovà, L. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345373 · Cited by 17
Heino, T. J., Chagin, A. S., Takigawa, M., & Savendahl, L. S. (2008) · Bone · doi:10.1016/j.bone.2008.01.001 · Cited by 17
Alendronate Improves Low Bone Mineral Density Induced by Steroid Therapy in Crohn's Disease
Tsujikawa, T., Andoh, A., Inatomi, O., Bamba, S., Nakahara, T., Sasaki, M., Saito, H., & Fujiyama, Y. (2009) · Internal Medicine · doi:10.2169/internalmedicine.48.2005 · Cited by 16
Andriani, A., Petrucci, M. T., Caravita, T., Montanaro, M., Villivà, N., Levi, A., Siniscalchi, A., Bongarzoni, V., Pisani, F., Muro, M., et al. (2012) · Blood Cancer Journal · doi:10.1038/bcj.2012.9 · Cited by 16
Shiomi, K., Nagata, Y., Kiyono, T., Harada, A., & Hashimoto, N. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12171 · Cited by 16
CONNEXIN 43 AND BONE: NOT JUST A GAP JUNCTION PROTEIN.
Plotkin, L. I. (2011) · Actualizaciones en osteología · Cited by 16
Self-citationSex-Dependent, Osteoblast Stage-Specific Effects of Progesterone Receptor on Bone Acquisition
Zhong, Z. A., Kot, A., Lay, Y.-A. E., Zhang, H., Jia, J., Lane, N. E., & Yao, W. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3186 · Cited by 16
Osteocyte apoptosis induces bone resorption and impairs the skeletal response to weightlessness
Bellido, T. (2007) · BoneKEy-Osteovision · doi:10.1138/20070272 · Cited by 16
Self-citationPrévention et traitement de l’ostéoporose cortisonique
Roux, C., & Orcel, P. (2003) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(03)00105-x · Cited by 16
Prevention and Treatment of Corticosteroid-Induced Osteoporosis
Iwamoto, J., Takeda, T., & Satō, Y. (2005) · Yonsei Medical Journal · doi:10.3349/ymj.2005.46.4.456 · Cited by 15
Glucocorticoid-Induced Osteoporosis
Leong, G. M., Jacqueline R. Center, Henderson, N. K., & Eisman, J. A. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50045-3 · Cited by 16
Fan, J., Liu, W., Zhu, X., Yi, H., Cui, S., Zhao, J., & Cui, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.13698 · Cited by 16
Wang, Y., Panasiuk, A., & Grainger, D. W. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100374n · Cited by 15
Connexin43 Modulation of Osteoblast/Osteocyte Apoptosis: A Potential Therapeutic Target?
Civitelli, R. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0811c · Cited by 15
Coffman, A. A., Basta‐Pljakic, J., Guerra, R. M., Ebetino, F. H., Lundy, M. W., Majeska, R. J., & Schaffler, M. B. (2021) · JBMR Plus · doi:10.1002/jbm4.10476 · Cited by 15
The inhibitory effect of bisphosphonates on glucocorticoid‐induced RANKL expression in human cells
Kobayashi, A., Hirano, F., & Makino, I. (2005) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740510026788 · Cited by 15
Calculating clinically relevant drug doses to use in animal studies
Fuchs, R. K., Allen, M. R., Condon, K. W., Reinwald, S., Miller, L. M., McClenathan, D. M., Keck, B. D., Phipps, R. J., & Burr, D. B. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0741-9 · Cited by 15
Fleisch, H. A., Reszka, A. A., Rodan, G. A., & Rogers, M. J. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1/50180-3 · Cited by 39
Molecular and Clinical Pharmacology of Calcitonin
Zaidi, M., Inzerillo, A. M., Troen, B. R., Moonga, B. S., Abe, E., & Burckhardt, P. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1.50184-0 · Cited by 15
Lee, Y.-J., Jeong, J., Seol, J., Xue, M., Jackson, C., & Park, S. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.16 · Cited by 14
Yamaza, H., Sonoda, S., Nonaka, K., Kukita, T., & Yamaza, T. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1042-7 · Cited by 14
Mazur, C. M., Castro, C. D., Tokavanich, N., Sato, T., Bruce, M., Brooks, D. J., Bouxsein, M., Wang, J. S., & Wein, M. N. (2022) · iScience · doi:10.1016/j.isci.2022.105019 · Cited by 15
Bisphosphonate Modulates Cementoblast Behavior In Vitro
Chun, Y. P., Foster, B. L., Lukasavage, P. A., Berry, J. E., Zhao, M., Tenenbaum, H. C., & Somerman, M. J. (2005) · Journal of Periodontology · doi:10.1902/jop.2005.76.11.1890 · Cited by 14
Graziani, F., Rosini, S., Cei, S., Ferla, F. L., & Gabriele, M. (2008) · Journal of Craniofacial Surgery · doi:10.1097/scs.0b013e3180a0331a · Cited by 14
Conners, C. M., Bhethanabotla, V. R., & Gupta, V. K. (2015) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.33527 · Cited by 14
Duesterdieck‐Zellmer, K. F., Driscoll, N., & Ott, J. F. (2012) · American Journal of Veterinary Research · doi:10.2460/ajvr.73.10.1530 · Cited by 14
Chou, M., Yan, D., Jafarov, T. H., & Everett, E. T. (2009) · Orthodontics and Craniofacial Research · doi:10.1111/j.1601-6343.2009.01447.x · Cited by 16
Qin, L., Choy, W., Au, S.-K., Fan, M., & Leung, P. (2007) · Journal of Orthopaedic Surgery and Research · doi:10.1186/1749-799x-2-9 · Cited by 14
Tomat, A. L., Gamba, C. A., Mandalunis, P., Grandi, D., Somoza, J., Friedman, S., & Zeni, S. N. (2005) · PubMed · Cited by 14
Review of New Guidelines for the Management of Glucocorticoid Induced Osteoporosis
Venuturupalli, S. R., & Sacks, W. L. (2013) · Current Osteoporosis Reports · doi:10.1007/s11914-013-0170-3 · Cited by 13
Biochemical markers of bone turnover in osteoporosis
Szulc, P., Bauer, D. C., & Eastell, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00065-4 · Cited by 14
Alendronate prolongs the reversal-resorption phase in human cortical bone remodeling
Borggaard, X. G., Roux, J.-P., Delaissé, J., Chavassieux, P., Andreasen, C. M., & Andersen, T. L. (2022) · Bone · doi:10.1016/j.bone.2022.116419 · Cited by 15
Glorieux, F. H., & Rowe, D. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-382040-2.10019-x · Cited by 13
Liu, C., Zhang, X., Wu, M. Y., & You, L. (2015) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2015.10.018 · Cited by 13
Dose-dependent differential effects of risedronate on gene expression in osteoblasts
Wang, J., & Stern, P. H. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.01.025 · Cited by 13
Dendritic polyglycerol anions for the selective targeting of native and inflamed articular cartilage
Reimann, S., Schneider, T., Welker, P., Neumann, F., Licha, K., Schulze-Tanzil, G. G., Wagermaier, W., Fratzl, P., & Haag, R. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb00618g · Cited by 13
Bone Disease after Bone Marrow Transplantation
Ebeling, P. R. (2005) · Elsevier eBooks · doi:10.1016/b978-012183502-6/50020-1 · Cited by 13
In whom and how to prevent glucocorticoid-induced osteoporosis
Adachi, J. D., & Papaioannou, A. (2005) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2005.07.002 · Cited by 13
Ho, J. W. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.12.002 · Cited by 13
Allen, M. R., & Aref, M. W. (2017) · Current Osteoporosis Reports · doi:10.1007/s11914-017-0361-4 · Cited by 13
Vascular malformations (II). Diagnosis, Pathology, and Treatment
Redondo, P. (2007) · Actas Dermo-Sifiliográficas · doi:10.1016/s1578-2190(07)70435-3 · Cited by 13
The Molecular Mechanisms of Action of Bisphosphonates
Thompson, K., & Rogers, M. J. (2007) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-007-9004-0 · Cited by 13
Bivi, N., Picotti, P., Mueller, L. N., Romanello, M., Moro, L., Quadrifoglio, F., & Tell, G. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.04.002 · Cited by 12
Osteoclasts are not crucial for hematopoietic stem cell maintenance in adult mice
Flores, C., Moscatelli, I., Thudium, C. S., Gudmann, N. S., Thomsen, J. S., Brüel, A., Karsdal, M. A., Henriksen, K., & Richter, J. (2013) · Haematologica · doi:10.3324/haematol.2013.089466 · Cited by 12
Treatment of osteoporosis: current state of the art
Hamrick, I., Schrager, S., & Nye, A. M. (2014) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-014-0335-4 · Cited by 12
Bisphosphonates in phenytoin-induced bone disorder
Khanna, S., Pillai, K. K., & Vohora, D. (2010) · Bone · doi:10.1016/j.bone.2010.10.172 · Cited by 12
Improving Combination Osteoporosis Therapy in a Preclinical Model of Heightened Osteoanabolism
Shao, Y., Hernandez-Buquer, S., Childress, P., Stayrook, K. R., Alvarez, M. B., Davis, H. M., Plotkin, L. I., He, Y., Condon, K. W., Burr, D. B., et al. (2017) · Endocrinology · doi:10.1210/en.2017-00355 · Cited by 13
Self-citationAlbu, P., Budiul, M. M., Mateescu, M., Chiriac, V., Vlase, G., & Vlase, T. (2017) · Journal of Thermal Analysis and Calorimetry · doi:10.1007/s10973-017-6537-4 · Cited by 12
Roelofs, A. J., Ebetino, F. H., Reszka, A. A., Russell, R. G. G., & Rogers, M. J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00095-1 · Cited by 12
Understanding osteoclast formation and function: implications for future therapies for osteoporosis
Zaidi, M., Moonga, B. S., Sun, L., Epstein, S., Huang, C. L.-H., & Abe, E. (2003) · Current Opinion in Orthopedics · doi:10.1097/00001433-200310000-00007 · Cited by 12
Orcel, P., & Roux, C. (2001) · Revue du Rhumatisme · doi:10.1016/s1169-8330(01)00181-8 · Cited by 12
Krüger, T. B., Syversen, U., Herlofson, B. B., Lian, A., & Reseland, J. E. (2022) · Acta Odontologica Scandinavica · doi:10.1080/00016357.2022.2072522 · Cited by 11
Tsuboi, K., Hasegawa, T., Yamamoto, T., Sasaki, M., Hongo, H., de Freitas, P. H. L., Shimizu, T., Takahata, M., Oda, K., Michigami, T., et al. (2016) · Histochemistry and Cell Biology · doi:10.1007/s00418-016-1450-7 · Cited by 11
Cha, M., Lee, K. M., & Lee, J. H. (2018) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-018-0127-9 · Cited by 11
Alendronate-induced Perturbation of the Bone Proteome and Microenvironmental Pathophysiology
Kim, J., Yeon, A., Parker, S. J., Shahid, M., Thiombane, A., Cho, E., You, S., Emam, H. A., Kim, D., & Kim, M. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.61552 · Cited by 11
Ezzat, B. A. (2010) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2010.07.006 · Cited by 11
The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation
Valenti, M. T., Giannini, S., Donatelli, L., Zanatta, M., Bertoldo, F., Sella, S., Vilei, M. T., Ossi, E., Realdi, G., Cascio, V. L., et al. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3122 · Cited by 10
Koo, C.-H., & Lee, J. (2018) · Maxillofacial Plastic and Reconstructive Surgery · doi:10.1186/s40902-018-0153-5 · Cited by 11
Corticosteroid-Induced Osteoporosis
Cranney, A., & Adachi, J. D. (2002) · Treatments in Endocrinology · doi:10.2165/00024677-200201050-00001 · Cited by 11
Genetic Approaches to Determine the Role of Glucocorticoid Signaling in Osteoblasts
Harrison, J. R., Woitge, H. W., & Kream, B. E. (2002) · Endocrine · doi:10.1385/endo:17:1:37 · Cited by 11
Liu, X., Bao, C., Hu, J., Yin, G., & Luo, E. (2010) · Archives of Medical Science · doi:10.5114/aoms.2010.17079 · Cited by 11
Klein‐Nulend, J., & Bonewald, L. F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00006-3 · Cited by 11
Metadata
- Authors
- Plotkin, L. I., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., & Bellido, T.
- Affiliations
- University of Arkansas for Medical Sciences (US)
- Central Arkansas Veterans Healthcare System (US)
- Corresponding author
- Bellido, Teresita
- Venue
- Journal of Clinical Investigation
- Published
- 1999-11-15
- Volume
- 104
- Issue
- 10
- Pages
- 1363-1374
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC409837
- OpenAlex
- W2170680219
- Cited by
- 890
- References
- 62
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 11 · 2023: 13 · 2022: 19 · 2021: 15 · 2020: 21 · 2019: 24 · 2018: 24 · 2017: 29 · 2016: 41 · 2015: 26 · 2014: 54 · 2013: 44 · 2012: 40
- FWCI
- 11.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ar043003-05)
- National Institute on Aging (P01AG/AMS13918, P01AG013918)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR43003, R01AR046191)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- bisphosphonates, calcitonin, osteocyte apoptosis, osteoblast apoptosis, glucocorticoid-induced osteoporosis, alendronate, etidronate, pamidronate, extracellular signal-regulated kinase, ERK1/2 phosphorylation, dexamethasone, TNF-α, etoposide, prednisolone, MLO-Y4 cells, trabecular bone
- MeSH terms
- Pamidronate, Animals, Calcitonin, Cell Line, Cells, Cultured, Dexamethasone, Diphosphonates, Etoposide, Osteoblasts, Osteocytes, Prednisolone, Skull, Etidronic Acid, Tumor Necrosis Factor-alpha, Apoptosis, Alendronate, In Situ Nick-End Labeling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
